Introduction
Infection of immunocompetent individuals by different pathogens may result in the establishment of an intense inflammatory response, leading to elimination of the infectious agent and cure of infection. Alternatively, it may trigger an immune response that is insufficient to control the pathogen fully, leading to the establishment of infection. In this case, either the individual will develop a severe disease and succumb to the infection, or the pathogen and the host will co-exist. The latter is the most common outcome in parasitic infections, where host survival is essential for the parasite [1] .
As an example, in chronic Chagas disease caused by infection with the protozoan parasite Trypanosoma cruzi, most patients ($70%) remain in a mild/asymtomatic form (named indeterminate, IND), while approximately 30% develop severe cardiac (CARD) and/or digestive clinical forms, associated with cumulative tissue damage due to a lifelong illness [2] . Cardiomyopathy is the most serious clinical outcome, responsible for at least 12 000 deaths every year and a global economic burden of more than 7 billion dollars/year [3] . The mechanisms underlying this distinct clinical progression are not understood completely, but it is evident that parasite strain and tissue tropism, parasite load, time of infection and host immune responses are critical [4, 5] . To date, there is no effective measure that can predict, prevent or revert disease progression in the chronic phase.
A predominantly anti-inflammatory cytokine profile is often observed in IND patients, while an inflammatory profile is clearly associated with CARD [1, 5] . Tumour necrosis factor (TNF) and interferon (IFN)-g expression have been associated with worse cardiac function [6] and with progression to severe forms of cardiomyopathy, respectively [7, 8] . Conversely, interleukin (IL)-10 and IL-17 expression have been associated with a controlled response observed in IND and better cardiac function [9] [10] [11] [12] . Monocytes and T cell subpopulations are major sources of the immunoregulatory cytokines produced in the chronic phase of Chagas disease [7, [13] [14] [15] .
We demonstrated recently that a minor subpopulation of T lymphocytes that do not express the co-receptors CD4 and CD8, named double-negative T cells (DN T cells), are involved actively in the production of cytokines in patients with different clinical forms of Chagas disease [16] . DN T cells can be divided further into two subpopulations, based on the expression of the alpha-beta or gamma-delta T cell receptors (TCR-ab and TCR-gd) [17] . These cells recognize mainly antigens presented via non-classic major histocompatibility complex (MHC) molecules belonging to the CD1 family [18] . We have demonstrated previously that, although both subsets of DN T cells can produce inflammatory and modulatory cytokines, the DN gd TCR subpopulation is a more pronounced source of IL-10 in IND patients, while expressing predominantly proinflammatory cytokines in CARD [16] . However, the antigenic components of T. cruzi that polarize DN T cell responses remain unknown.
The T. cruzi surface is covered by a complex array of different molecules that include glycosylphosphatidylinositol (GPI)-anchored glycoconjugates such as GPI-mucins, mucin-associated surface proteins (MASP), trans-sialidases (TS) and glycoinositol phospholipids (GIPLs). Those molecules may also be present in extracellular vesicles (EVs) shed by the parasites [19, 20] . GPI-mucins, GIPLs and EVs exhibit high structural diversity and antigenicity depending on the strain and/or life stage of the parasite [21] [22] [23] [24] . These molecules, which act as pathogen-associated molecular patterns (PAMPs), are Toll-like receptor agonists (TLR-2, -4 and -6), triggering cytokine and chemokine production, and promoting recruitment and activation of phagocytic cells [25] [26] [27] .
The high diversity of T. cruzi antigens may have an implication in the immunopathogenic events not only in the acute but also in the chronic phase of Chagas disease. Processing and presentation of different parasite components provide a plethora of stimulus that leads to establishment of T cell-mediated adaptive responses. Thus, different parasite components may induce functionally distinct T cell responses, which may be associated with distinct disease outcomes [28, 29] . Given the importance of DN T cells as cytokine producers during chronic Chagas disease, and their clear association with distinct clinical forms, the aim of this study was to determine which components of T. cruzi trigger activation of these cells in human Chagas disease. Our results showed that glycolipid-enriched fractions (GCL), but not protein (PRO)-or lipid (LIP)-enriched fractions, led to activation of DN T cells, especially the TCR-gd subpopulation, from IND and CARD patients. Moreover, GCL induced preferential expression of IFN-g by activated DN TCR-gd from CARD but not IND, leading to the predominance of an inflammatory milieu in CARD, as measured by the increased IFN-g/IL-10 ratio. Although GCL led to higher expression of TNF and IL-10 by DN T cells from IND, the TNF/IL-10 ratio remained unaltered. Thus, the induction of TNF was not sufficient to shift the response towards an inflammatory profile. These results identify GCL as the major T. cruzi component responsible for activation of DN T cells, associated predominantly with an inflammatory profile in CARD Chagas patients. These results suggest that modulating the response to GCL may be a valid strategy for controlling inflammation-induced cardiomyopathy.
Patients, material and methods

Patients
A total of 18 volunteers were enrolled into in this study. Twelve volunteer patients had positive specific serology for T. cruzi and were within the chronic phase of the disease, with extremely well-defined and polar clinical forms; six individuals displayed negative specific serological tests for Chagas disease and were included as a control group. Patients were from Chagas disease endemic areas within Minas Gerais, Brazil, and were evaluated at the out-patient clinic of the Universidade Federal de Minas Gerais. These patients have been followed for more than 10 years, and repeated evaluations confirmed the clinical forms. In additional to standard serology examinations, physical examinations, electrocardiogram, chest X-rays and echocardiogram were performed with the purpose of characterizing the clinical status of the patients, as defined previously [30] . Indeterminate Chagas patients (IND; n 5 6; age range 5 34-69 years; four females and two males) had positive serology, lack of clinical manifestations or alterations upon clinical, radiological and echocardiographic examination. Cardiac Chagas patients (CARD; n 5 6; age range 5 18-72 years; four females and two males) displayed positive serology, right and/or left ventricular dilation, global left ventricular dysfunction, alterations in the cardiac electric impulse generation and conduction upon electrocardiogram, chest X-rays and echocardiography. We excluded from our study individuals with any other chronic inflammatory diseases, diabetes, heart/circulatory illnesses or bacterial infections. All individuals included in this work were volunteers and treatment and clinical care was offered to all patients as needed, despite their enrollment into this research project. This crosssectional study is part of an extended project evaluating DN T cell and T. cruzi glycolipids 
Parasites and fractions
T. cruzi trypomastigotes of the CL Brener clone were grown in Vero cells, as performed previously by us [9] . Briefly, cells were infected with 10 trypomastigotes/cell and, after removal of free trypomastigotes by washing with culture media, were maintained in RPMI enriched with 5% fetal calf serum and antibiotic (penicillin 500 U/ml and streptomycin 0Á5 mg/ml) for approximately 6 days. After this period, trypomastigotes ruptured the cells and were collected from the supernatant, centrifuged, resuspended in phosphate-buffered saline (PBS) and then washed twice with phosphate-buffered saline (PBS) by centrifugation (800 g for 5 min at 48C). Parasites obtained in such a manner were stored at 2808C as dry pellets; 2 3 10 9 tripomastigotes prepared as described previously were used for subsequent antigen fractionation.
T. cruzi fractions were obtained using the methodology published previously [22, 31] , with some changes. Briefly, frozen pellets obtained as described above were suspended in 1Á6 ml of ultrapure water and transferred to 13 3 100-mm polytetrafluoroethylene (PTFE)-lined screw capped Pyrex culture tubes. Chloroform and methanol were added to each vial at a final ratio of chloroform/methanol/water (C/M/W) of 1 : 2 : 0.8 (v/v/v). Samples were mixed vigorously using a vortex for 2 min and then centrifuged for 15 min at 1800 g at room temperature; this process was repeated three times. Pellet was extracted once again with C/M (2 : 1, v/v), samples were mixed vigorously for 2 min using a vortex and then centrifuged for 15 min at 1800 g at room temperature. Insoluble tripomastigote debris were stored for later extraction of proteins. At the end of each step of extraction, the supernatants were transferred to PTFE-lined Pyrex glass test tubes and then dried on a lyophilizer. Next, samples were pooled together and subjected to Folch's partition [32] . Briefly, sample was dissolved in C/ M/W (4 : 2 : 1Á5, v/v/v) and then mixed vigorously for 5 min using a vortex and finally centrifuged for 15 min at 1800 g at room temperature. After centrifugation, a lower (organic) phase containing lipids and an upper (aqueous) phase containing glycolipids were obtained. Once again samples were dried by lyophilizing. The lipid fraction (LIP antigen, which contains mainly neutral membrane lipids) was resuspended in 1Á0 ml of dimethylsulphoxide (DMSO). One millilitre of ultrapure water was added to the tube containing the glycolipids (GCL antigens). All fractions were in stored in sterile glass tubes at 2808C until use.
For T. cruzi protein extraction, we used the remaining insoluble material from lipid and glycolipid extraction, as described Almeida et al. (2000) [22] . In brief, parasite debris was extracted three times with 10 volumes of butan-1-ol-saturated water (9% butan-1-ol) for 4 h under agitation at room temperature. The resulting extracts were combined in a single vial and dried on the lyophilizer. Protein fraction extract (PRO antigen, which contains proteins and glycoproteins) was resuspended in 1Á0 ml of ultrapure water and stored at 2808C until use.
Blood sampling and in-vitro cultures
Peripheral blood samples were collected from all 18 volunteers enrolled into this study in heparin tubes. Peripheral blood mononuclear cells (PBMCs) were obtained by separating whole blood over Ficoll (Sigma Chemical Co., St Louis, MO, USA), as described previously by us [33] . The cells were washed and resuspended in RPMI-1640 medium (Gibco, Rockville, MD, USA) supplemented with 5% heatinactivated AB human serum (Sigma-Aldrich, St Louis, MO, USA), antibiotics (penicillin, 200 U/ml and streptomycin, 0Á1 mg/ml) and L-glutamine (1 mM) (SigmaAldrich) at a concentration of 1 3 10 7 cells/ml. Cells from each volunteer were placed on 96-well plates (Costar, Corning Incorporated, Corning, NY, USA) in 200 ll cultures under the following conditions: medium alone, GCL fraction (20 lg/ml), LIP fraction (equal to five parasites) and PRO fraction (equal to 10 parasites) for 14 and 36 h. The concentration of each stimulus in culture was determined based on previous tests performed by us using the expression of CD69 in DN T cells as a parameter of activation [34] . GCL fraction was measured using the phenol-sulphuric acid method [35] , while LIP and PRO fractions were extrapolated from the number of parasites used for the extraction. Brefeldin A (10 lg/ml) was added for the last 4 h of culture to prevent cytokine secretion.
Flow cytometric analysis
Immunophenotypical analyses of peripheral blood mononuclear cells (PBMCs) exposed to the different stimuli were performed by multi-parametric flow cytometry to determine the activation status and cytokine production by the DN T cell subsets. Stimulated (treated as described above) or non-stimulated cells were harvested after the final 18 or 40 h of culture and submitted to specific staining. We used combinations of monoclonal antibodies (mAbs) specific for human leucocyte cell-surface markers, including: BV510-labelled anti-CD4, allophycocyanin-cyanin 7 (APCCy7)-labelled anti-CD8, BV421-labelled anti-TCR-ab and APC-labelled anti-TCR-gd to identify the specific subpopulations of DN T cells. A 40-ll mixture of these surface antibodies was added to each well of a 96-well round-bottomed plate containing 2 3 10 5 cells for 15 min at 48C, washed in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA), and fixed by a 20-min incubation with a 2% formaldehyde solution. After removal of the fixing solution by centrifugation and washing with PBS, we permeabilized the cells by incubation for 15 min with a 0Á5% saponin solution, and proceeded to intracellular staining. Samples were incubated with phycoerythrin (PE)-Cy7-labelled anti-IL-10 or CD69, PE-labelled anti-IFN-g or TNF monoclonal antibodies for 20 min at room temperature, washed twice with 0Á5% saponin solution, resuspended in PBS and read in a flow cytometer. A minimum of 100 000 gated events from each sample were collected and analysed using FlowJo software (TreeStar, Inc., Ashland, OR, USA). All antibodies were from BioLegend (San Diego, CA, USA).
Statistical analysis
All data showed a Gaussian distribution, as determined by Kolmogorov-Smirnov test. Paired t-test was used to ascertain differences between unstimulated cultures and stimulated cultures within the same group of patients. Comparisons between different groups were performed using unpaired t-test. Differences that returned P-values of less than or equal to 0Á05 were considered statistically significant from one another.
Results
Glycolipid-enriched fractions lead to increased activation of DN T cells from Chagas patients
We have shown previously that DN T cells from Chagas patients expand upon exposure to live T. cruzi trypomastigotes, and this expansion is accompanied by the production of immunoregulatory cytokines [16, 36] . To determine which component(s) of T. cruzi trypomastigotes was (were) responsible for DN T cell activation, we fractionated the trypomastigote forms, as described above, and obtained GCL, LIP and PRO fractions. These fractions were used to stimulate PBMC from Chagas patients of the IND and CARD forms, as well as from non-Chagas patients (healthy) as controls. As a measure of DN T cell activation, we evaluated the expression of the activation marker, CD69, by the TCR-ab and TCR-gd DN T cell subpopulations.
We observed that LIP and PRO fractions did not lead to a significant increase in the activation status of DN TCRab or DN TCR-gd cell subpopulations (Fig. 1a,b , respectively) from Chagas patients or from non-Chagas individuals, compared to non-stimulated cultures. Conversely, GCL led to a significant increase in CD69 expression in DN TCR-ab cells from IND (Fig. 1a) and by DN TCR-gd cells from IND, as well as CARD (Fig. 1b) . Expression of CD69 by DN T cells from non-Chagas individuals did not return statistically significant results.
Previous studies have shown that T. cruzi molecules can stimulate CD4
1 and CD8 1 T cells [37] [38] [39] [40] . We then evaluated the expression of CD69 by CD4 1 and CD8 1 cells stimulated with GCL to determine whether we would also observe activation of these cells and, if so, if the magnitude of activation was similar to the one observed in DN T cells. We observed that GCL led to a slight increase in the activation of T cells from IND and CARD Chagas patients, especially CD4 1 T cells (Fig. 2) . CD4 1 or CD8 1 T cells from non-Chagas individuals did not show up-regulation of CD69 upon stimulation with GCL (Fig. 2) . Interestingly, although the threshold of CD69 expression is already higher in DN T cells compared with CD4 1 and CD8 1 cells, as observed in non-stimulated cultures, the magnitude of activation of DN T cells after GCL stimulation is at least three times higher than that observed in CD4 1 and CD8
1
T cells (Fig. 2) . These data show that, although GCL can stimulate CD4 1 and CD8 1 cells, it stimulates DN T cells preferentially.
Activation induced by glycolipid-enriched fractions is accompanied by the expression of TNF and IFN-g by DN T cells from indeterminate and cardiac Chagas patients, respectively
To determine if the activation induced by the GCL was accompanied by a functional activation, we evaluated the expression of TNF, IFN-g and IL-10 by the different DN T cell subpopulations. DN TCR-ab cells did not express statistically significant alterations in the frequency of cytokines upon stimulation with GCL in any of the groups (Fig. 3a-c) , despite the observed increase in CD69 expression in DN TCR-ab cells from IND (Fig. 1a) . The other stimuli (LIP and PRO) also did not induce significant changes in the expression of any of the evaluated cytokines by TCR-ab DN T cells from Chagas patients, regardless of the clinical form, or from non-Chagas patients (data not shown). We observed that GCL induced a higher expression of TNF and IL-10 ( Fig. 3d,f) in DN TCR-gd cells from IND, while inducing an increase in the expression of IFN-g in DN T cells from CARD (Fig. 3e) . To determine if CGL stimulation led to changes in the balance between the expression of inflammatory and antiinflammatory cytokines in the DN TCR-gd cells, which were stimulated preferentially by GCL, we calculated the ratio between the percentage of DN TCR-gd cells expressing TNF/IL-10 and IFN-g/IL-10 before and after stimulation with GCL. Our analysis showed that the TNF/IL-10 ratio in DN TCR-gd cells did not change significantly after GCL stimulation in any of the analysed groups compared to nonstimulated cultures (Fig. 4) . Conversely, while we observed a slight decrease in the IFN-g/IL-10 ratio in DN TCR-gd cells from IND after stimulation with GCL compared to media control, this ratio was increased significantly in DN TCR-gd cells from CARD (Fig. 4) . Moreover, the IFN-g/IL-10 ratio in DN TCR-gd cells from CARD after GCL stimulation was statistically greater than the one from non-Chagas individuals stimulated with GCL (Fig. 4) . (Fig. 5a,c) . GCL stimulus did not affect the production of cytokines by CD8 1 cells from CARD or healthy individuals (Fig. 5a-c) . Expression of IFN-g by CD8
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1 cells was not altered after GCL stimulation in any of the analysed groups (Fig. 5b) . The glycolipidenriched fraction did not alter the functional activity of CD4 1 T lymphocytes from healthy, IND or CARD (Fig. 5d-f) . 
Discussion
The T. cruzi surface is decorated with a large variety of molecules that, in addition to participating in the host-parasite interaction, display antigenic characteristics. Among the main components of the T. cruzi cell surface, glycoconjugates have been studied widely, especially GIPLs and GPI mucins. It has been shown that they mediate cellular invasion and evasion of the immune system directly [41] . Studies in the experimental model of T. cruzi infection also showed that these molecules display a proinflammatory activity, inducing the expression of inflammatory cytokines by macrophages and T cells [22, 42] . GIPLs, a class of GCL, from various parasites such as T. cruzi, Toxoplasma gondii and Plasmodium falciparum can induce the production of proinflammatory cytokines mediated by TLR-4 [26, 43, 44] . However, by reducing the expression of co-stimulatory and activation molecules, as well as cytokine production, a modulatory effect of GIPLs on human macrophages and dendritic cells has also been demonstrated [45] .
In recent years, DN T cells have emerged as important sources of immunoregulatory cytokines in infectious diseases such as leishmaniasis, tuberculosis and Chagas disease [16, 36, 46, 47] . In Chagas disease, these cells express inflammatory and anti-inflammatory cytokine profiles, associated with the cardiac and indeterminate forms, respectively [16] . The mechanisms of activation of these cells, as well as the molecules responsible for their activation, have not yet been elucidated. In this work, we studied the ability of different components of T. cruzi in stimulating DN T cells. We observed that the glycolipid-enriched fraction (GCL) is the most important component from T. cruzi in the activation of DN T cells, while lipid (LIP)-and protein (PRO)-enriched fractions are not efficient stimulators of DN T cells from Chagas patients. Moreover, we observed that GCL induces a higher expression of TNF and IL-10 in cells from indeterminate patients (IND), while the expression of IFN-g was increased only in cells from cardiac Chagas patients (CARD). Importantly, the TNF/IL-10 ratio did not change significantly indicating that, although TNF was induced by GCL in DN T cells from IND, it was not enough to induce a more inflammatory profile in these patients. Conversely, the IFN-g/IL-10 ratio increased in CARD, indicating that the magnitude of the increase in IFN-g expression induced by GCL stimulation influenced the cytokine milieu. Although GCL also stimulates CD4 1 
and CD8
1 T cells, the magnitude of this stimulation is significantly greater in DN T cells. Thus, our data show that GCL is a potent activator of DN T cells, especially TCR-gd, and that this activation is responsible for the induction of an inflammatory environment in DN T cells from CARD, but not IND. Thus, modulating the inflammatory response of DN T cells to GCL may emerge as an alternative approach for avoiding or, at least, controlling Chagas cardiac pathology.
One of the measures of activation used in our work was the expression of CD69. We observed that GCL-stimulated DN T cells from CARD and IND, but not from nonChagas patients, expressed CD69. This activation was observed mainly in DN TCR-gd cells compared to the ab subpopulation and, although CD4 1 and CD8 1 T cells also were slightly activated, the magnitude of their activation was much lower than that of DN T cells. Medeiros et al. (2007) [48] observed that, as a result of activation of mouse macrophages treated with GIPLs, T and B lymphocytes from the spleen and lymph nodes of these animals displayed increased CD69 expression, showing an indirect effect of GIPL stimulation on these cells. In our study, the fact that the activation was observed only in DN TCR-gd cells and only slightly in CD4 1 and CD8 1 T cells, suggests that this was a direct stimulation of DN TCR-gd cells by GCL.
The reasons why most of the response of DN T cells to GCL is concentrated in the TCR-gd subpopulation are not clear. However, several studies have shown that ab and gd DN subpopulations display a distinct repertoire and activation requirements. While DN TCR-ab cells display a polyclonal repertoire with MHC restriction [17, 49, 50] , DN TCR-gd cells display a somewhat oligoclonal repertoire [18] which could explain why certain preparations, such as GCL, stimulate one population more effectively than the other. It is possible that this stimulation occurs via activation of Toll-like receptor agonists present in the GCL preparation. This is an important point that merits future investigation. That GCL activates DN TCR-gd cells preferentially may prove beneficial for implementation of immunomodulatory treatments that block the response of DN TCR-gd cells to GCL in attempts to control inflammation and, thus, pathology development in Chagas disease. The ability to interfere with one population individually and not affect the response of others may offer an additional advantage toward the use of this strategy.
Previous studies have shown that DN T cells respond to lipid antigens presented via CD1 molecules [51, 52] . It is puzzling that the T. cruzi-derived LIP fraction did not induce activation of DN T cells in our study. However, it is important to note that most lipids present in the LIPenriched fraction are neutral lipids [31] and possibly with less immunogenic potential. In addition, GCL fraction is indeed the fraction that contains highly immunogenic lipids such as GIPLs and possibly others, which explains its stimulatory capacity over DN T cells. Previous studies have also shown that GIPLs can lead to inflammatory, but also anti-inflammatory, responses in human cells [22, 42, 45] . Here, we observed that GCL led to inflammatory and anti-inflammatory responses in DN T cells from CARD and IND, respectively. Given the complexity of the GCL fraction, it is possible that DN T cells from IND and CARD are activated by different components, leading to mobilization of distinct stimulatory pathways. Alternatively, if the cells from CARD and IND are responding to a dominant antigen, the difference in the response could be a result of the overall inflammatory and antiinflammatory milieu observed in these patients, respectively, possibly associated to a different priming/response in patients with different clinical forms. Previous studies have shown that GCL from trypomastigote forms of the CL Brener clone, which was used in this study, include mainly alkylacylglycerol and dihydroceramide-containing GIPL [42] , but that it also may contain other components such as phosphoinositols and inositol phospatidylcholine [53] . Given the high immunogenicity of the different GIPLs, molecular characterization of the GCL fraction, as well as testing of its individual constituents, need to be performed to identify precisely the component(s) responsible for this differential activation in IND and CARD. This analysis will be instrumental to aid in developing tools to control the response to GCL as a possible strategy to block or control pathology.
Our study employs components derived from the trypomastigote form of T. cruzi, which provides important information towards defining the activating ability of molecules derived from a parasite stage that is found in the host. Because of its role in activating the immune response, GPI mucins and GIPLs are being used as adjuvants in immunization protocols against T. cruzi, with the hope of finding effective vaccines [54] . To date, the efforts have not led to highly effective protective responses. Our study emphasizes the importance of considering the response mounted by DN T cells in vaccination efforts, given their prominent response to GIPL, which may influence the success (or not) of a given vaccine.
In conclusion, our study shows that GCL are the main fraction of T. cruzi responsible for the activation of DN TCR-gd cells in Chagas patients, and for the induction of an inflammatory profile in cardiac but not indeterminate patients. Thus, considering the possible influence of this activation in the overall response of the patients, which is yet to be evaluated, it is possible that the control of DN TCR-gd cells in Chagas patients may emerge as a potentially preventive inducer of pathology development. Determining the fine molecular composition of GCL, as well as the mechanisms of GCL-induced activation, will clarify important points towards defining possible strategies to modulate the inflammatory response in cardiac Chagas patients.
